NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: March 2024
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Renovaro Biosciences Inc. (“Renovaro” or the “Company”) (NASDAQ: RENB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Renovaro Biosciences Inc. (“Renovaro” or the “Company”) (NASDAQ: RENB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zillow Group, Inc. (“Zillow” or the “Company”) (NASDAQ: Z). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zillow Group, Inc. (“Zillow” or the “Company”) (NASDAQ: Z). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CI&T Inc. (“CI&T” or the “Company”) (NYSE: CINT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of CI&T Inc. (“CI&T” or the “Company”) (NYSE: CINT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Trupanion Inc. (“Trupanion” or the “Company”) (NASDAQ: TRUP). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
NEW YORK, March 11, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Trupanion Inc. (“Trupanion” or the “Company”) (NASDAQ: TRUP). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The…
DUBLIN, March 11, 2024 /PRNewswire/ — The “Omics Lab Services Market – Forecasts from 2024 to 2029” report has been added to ResearchAndMarkets.com’s offering. The omics lab services market was valued at US$98.8 billion in 2022 and is expected to grow at a CAGR of 15.17% during the…